Skip to content

Application of nano-platelet in the repair of refractory wounds

Application of nano-platelet in the repair of refractory wounds

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086652
Enrollment
Unknown
Registered
2024-07-08
Start date
2024-07-09
Completion date
Unknown
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory wounds

Interventions

Sponsors

department of Orthopedic surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) 18-90 years old 2) Leg ulcers, which can be caused by any of the following: diabetes, venous insufficiency, trauma, surgery, and pressure 3) The wound area > 0.5 cm2 4) There was no trend towards healing after 4 weeks of regular treatment 5) Voluntarily participate in this study, and sign the informed consent form

Exclusion criteria

Exclusion criteria: 1) Active cellulitis 2) osteomyelitis 3) gangrene 4) ABI 1.3 5) Revascularization was performed in the last 6 weeks(Ipsilateral lower extremity) 6) Taken any experimental drug or applied topically to the wound 4 weeks prior to the study 7) Presence of significant medical conditions that would impair wound healing, such as aplastic anemia, liver disease, scleroderma, malignancy, or immunosuppressive therapy 8) Patients who are participating in other clinical trials 9) Specimen collection was not satisfactory 10) Vulnerable groups, including people with mental illness, cognitive impairment, critically ill patients, minors, pregnant women, etc. 11) Other reasons that are considered unsuitable by the investigators to participate in this study

Design outcomes

Primary

MeasureTime frame
wound area;immunofluorescence;

Secondary

MeasureTime frame
RNA sequence;

Countries

China

Contacts

Public Contactxianfeng lin

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

Xianfeng_lin@zju.edu.cn+86 152 6884 3719

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026